Neuronetics, Inc. (STIM)
USD 1.37
(5.38%)
USD 1.37
(5.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -22.75 Million USD | 8.68% |
| 2022 | -31.26 Million USD | -19.71% |
| 2021 | -26.55 Million USD | -23.96% |
| 2020 | -21.06 Million USD | 13.29% |
| 2019 | -26.93 Million USD | -24.41% |
| 2018 | -19.52 Million USD | -54.3% |
| 2017 | -12.57 Million USD | -45.03% |
| 2016 | -8.72 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -7.95 Million USD | -33.02% |
| 2024 Q1 | -6.29 Million USD | -81.03% |
| 2023 Q3 | -7.7 Million USD | -135.79% |
| 2023 FY | - USD | 8.68% |
| 2023 Q1 | -8.75 Million USD | -23.65% |
| 2023 Q2 | -3.26 Million USD | 62.64% |
| 2023 Q4 | -3.92 Million USD | 49.09% |
| 2022 Q3 | -6.16 Million USD | 34.61% |
| 2022 FY | - USD | -19.71% |
| 2022 Q1 | -9.54 Million USD | -45.2% |
| 2022 Q2 | -9.42 Million USD | 1.25% |
| 2022 Q4 | -7.07 Million USD | -14.87% |
| 2021 Q1 | -6.61 Million USD | -150.0% |
| 2021 Q4 | -6.57 Million USD | 5.34% |
| 2021 Q3 | -6.94 Million USD | -10.59% |
| 2021 Q2 | -6.27 Million USD | 5.11% |
| 2021 FY | - USD | -23.96% |
| 2020 Q4 | -2.64 Million USD | -19.78% |
| 2020 Q2 | -6.54 Million USD | 33.64% |
| 2020 Q3 | -2.2 Million USD | 66.25% |
| 2020 FY | - USD | 13.29% |
| 2020 Q1 | -9.86 Million USD | -48.37% |
| 2019 FY | - USD | -24.41% |
| 2019 Q4 | -6.64 Million USD | -18.12% |
| 2019 Q3 | -5.62 Million USD | 4.75% |
| 2019 Q2 | -5.91 Million USD | 7.74% |
| 2019 Q1 | -6.4 Million USD | -23.1% |
| 2018 Q4 | -5.2 Million USD | -36.05% |
| 2018 FY | - USD | -54.3% |
| 2018 Q3 | -3.82 Million USD | 39.01% |
| 2018 Q2 | -6.27 Million USD | -41.36% |
| 2018 Q1 | -4.43 Million USD | -9.75% |
| 2017 FY | - USD | -45.03% |
| 2017 Q1 | -3.79 Million USD | 0.0% |
| 2017 Q4 | -4.04 Million USD | -44.5% |
| 2017 Q3 | -2.79 Million USD | -38.86% |
| 2017 Q2 | -2.01 Million USD | 46.96% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 89.345% |
| Prenetics Global Limited | -47.89 Million USD | 52.483% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -1249.081% |
| CareDx, Inc | -89.65 Million USD | 74.615% |
| Exact Sciences Corporation | 41.87 Million USD | 154.349% |
| Exagen Inc. | -19.15 Million USD | -18.827% |
| Inotiv, Inc. | -26.5 Million USD | 14.136% |
| Guardant Health, Inc. | -433.3 Million USD | 94.748% |
| Biodesix, Inc. | -37.1 Million USD | 38.66% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -815.796% |
| Precipio, Inc. | -4.31 Million USD | -427.073% |
| iSpecimen Inc. | -9.1 Million USD | -149.997% |
| Natera, Inc. | -383.27 Million USD | 94.062% |
| Aspira Women's Health Inc. | -16.49 Million USD | -38.009% |
| Standard BioTools Inc. | -54.45 Million USD | 58.207% |
| 23andMe Holding Co. | -291.87 Million USD | 92.202% |
| Castle Biosciences, Inc. | -45.02 Million USD | 49.451% |
| Personalis, Inc. | -96.8 Million USD | 76.49% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 80.641% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -137.294% |
| OpGen, Inc. | -29.51 Million USD | 22.88% |
| T2 Biosystems, Inc. | -43.87 Million USD | 48.128% |
| Myriad Genetics, Inc. | -67.8 Million USD | 66.432% |
| ICON Public Limited Company | 1.63 Billion USD | 101.395% |
| NeoGenomics, Inc. | -17.6 Million USD | -29.261% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -1249.081% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 101.869% |
| RadNet, Inc. | 292.78 Million USD | 107.773% |
| MDxHealth SA | -30.46 Million USD | 25.302% |
| Psychemedics Corporation | -251 Thousand USD | -8967.331% |
| Illumina, Inc. | -608 Million USD | 96.257% |
| Check-Cap Ltd. | -17.64 Million USD | -28.953% |
| Twist Bioscience Corporation | -176.7 Million USD | 87.12% |
| DarioHealth Corp. | -53.49 Million USD | 57.455% |
| Fulgent Genetics, Inc. | -46.55 Million USD | 51.111% |
| Sera Prognostics, Inc. | -35.28 Million USD | 35.503% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -132.595% |
| OPKO Health, Inc. | -65.51 Million USD | 65.262% |
| Medpace Holdings, Inc. | 363.15 Million USD | 106.267% |
| Neogen Corporation | 182.59 Million USD | 112.464% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -158.311% |
| Prenetics Global Limited | -47.89 Million USD | 52.483% |
| Mainz Biomed B.V. | -25.01 Million USD | 9.005% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -198.31% |
| Trinity Biotech plc | -24.09 Million USD | 5.556% |
| Sotera Health Company | 514.14 Million USD | 104.427% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -198.31% |